To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Synthetic vaccine

From Wikipedia, the free encyclopedia

A synthetic vaccine is a vaccine consisting mainly of synthetic peptides, carbohydrates, or antigens. They are usually considered to be safer than vaccines from bacterial cultures. Creating vaccines synthetically has the ability to increase the speed of production. This is especially important in the event of a pandemic.

YouTube Encyclopedic

  • 1/3
    Views:
    840
    1 947
    753
  • Synthetic Vaccines & the A.I. Lock-Down
  • Treating Allergies: The Production of a Peptide Vaccine
  • Mod-21 Lec-39 Synthetic vaccines

Transcription

History

The world's first synthetic vaccine was created in 1796 from diphtheria toxin by Louis Chedid (scientist) from the Pasteur Institute and Michael Sela from the Weizmann Institute.[citation needed]

In 1986, Manuel Elkin Patarroyo created the SPf66, the first version of a synthetic vaccine for Malaria.[1]

During the H1N1 outbreak in 2009, vaccines only became available in large quantities after the peak of human infections. This was a learning experience for vaccination companies. Novartis Vaccine and Diagnostics, among other companies, developed a synthetic approach that very rapidly generates vaccine viruses from sequence data in order to be able to administer vaccinations early in the pandemic outbreak. Philip Dormatizer, the leader of viral vaccine research at Novartis, says they have "developed a way of chemically synthesizing virus genomes and growing them in tissue culture cells".[2]

Phase I data of UB-311, a synthetic peptide vaccine targeting amyloid beta, showed that the drug was able to generate antibodies to specific amyloid beta oligomers and fibrils with no decrease in antibody levels in patients of advanced age. Results from the Phase II trial are expected in the second half of 2018.[3][4]

References

  1. ^ Patarroyo, Manuel E. (May 30, 2007). "Synthetic vaccine update: Applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization". Vaccine. 25, 22 (22): 4487–4501. doi:10.1016/j.vaccine.2007.03.016. PMID 17403557.
  2. ^ Young Rojahn, Susan (May 14, 2013). "Synthetic Biology Could Speed Flu Vaccine Production". MIT Technology Review.
  3. ^ "Archived copy". Archived from the original on 2019-06-17. Retrieved 2017-11-09.{{cite web}}: CS1 maint: archived copy as title (link)[full citation needed]
  4. ^ Wang, Chang Yi; Wang, Pei-Ning; Chiu, Ming-Jang; Finstad, Connie L; Lin, Feng; Lynn, Shugene; Tai, Yuan-Hung; De Fang, Xin; Zhao, Kesheng; Hung, Chung-Ho; Tseng, Yiting; Peng, Wen-Jiun; Wang, Jason; Yu, Chih-Chieh; Kuo, Be-Sheng; Frohna, Paul A (2017). "UB-311, a novel UBITh ® amyloid β peptide vaccine for mild Alzheimer's disease". Alzheimer's & Dementia: Translational Research & Clinical Interventions. 3 (2): 262–272. doi:10.1016/j.trci.2017.03.005. PMC 5651432. PMID 29067332.

External links

This page was last edited on 26 July 2023, at 01:08
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.